Meeting
2016 Gastrointestinal Cancers Symposium
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in pancreatic neuroendocrine tumors (PanNET).
Authors
Antonio Viudez
Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
Antonio Viudez , Filipe LF Carvalho , Zahra Maleki , Marianna Zahurak , Daniel A. Laheru , Alejandro Stark , Nilofer Saba Azad , Christopher Lee Wolfgang , Stephen Baylin , James Gordon Herman , Ana De Jesus-Acosta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 241)
DOI
10.1200/jco.2016.34.4_suppl.241
Abstract #
241
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
First Author: Ahmet Bilici
Poster
2018 ASCO Annual Meeting
Mechanisms of immune evasion in triple-negative breast cancer patients.
First Author: Javier Ignacio Orozco
Poster
2018 Gastrointestinal Cancers Symposium
The expression of versican and its role in pancreatic neuroendocrine tumors.
First Author: Zhao Sun
Poster
2017 ASCO Annual Meeting
FGFR3 correlation with mutant p53 and its prognostic value in oropharyngeal squamous cell carcinoma (OPSCC).
First Author: Zhuo Georgia Chen